YU47699A - Derivat hinolin -2-karboksilne kiseline i njegova upotreba kao antagonist ekscitatornih amino kiselina - Google Patents
Derivat hinolin -2-karboksilne kiseline i njegova upotreba kao antagonist ekscitatornih amino kiselinaInfo
- Publication number
- YU47699A YU47699A YU47699A YU47699A YU47699A YU 47699 A YU47699 A YU 47699A YU 47699 A YU47699 A YU 47699A YU 47699 A YU47699 A YU 47699A YU 47699 A YU47699 A YU 47699A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- carboxylic acid
- amino acids
- quinoline
- antagonists
- excitatory amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9706294.7A GB9706294D0 (en) | 1997-03-26 | 1997-03-26 | Heterocyclic compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU47699A true YU47699A (sh) | 2001-12-26 |
Family
ID=10809909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU47699A YU47699A (sh) | 1997-03-26 | 1998-03-24 | Derivat hinolin -2-karboksilne kiseline i njegova upotreba kao antagonist ekscitatornih amino kiselina |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0971896A1 (xx) |
| JP (1) | JP2001518901A (xx) |
| KR (1) | KR20010005567A (xx) |
| CN (1) | CN1257482A (xx) |
| AP (1) | AP9901659A0 (xx) |
| AU (1) | AU731394B2 (xx) |
| BR (1) | BR9808424A (xx) |
| CA (1) | CA2284710A1 (xx) |
| EA (1) | EA199900755A1 (xx) |
| GB (1) | GB9706294D0 (xx) |
| HU (1) | HUP0001661A3 (xx) |
| ID (1) | ID24306A (xx) |
| IL (1) | IL131919A0 (xx) |
| IS (1) | IS5186A (xx) |
| NO (1) | NO994679L (xx) |
| NZ (1) | NZ337793A (xx) |
| PL (1) | PL335865A1 (xx) |
| TR (1) | TR199902315T2 (xx) |
| WO (1) | WO1998042673A1 (xx) |
| YU (1) | YU47699A (xx) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9917822D0 (en) * | 1999-07-29 | 1999-09-29 | Imperial College | Nmda antagonist |
| DE10132725A1 (de) | 2001-07-05 | 2006-08-03 | Grünenthal GmbH | Substituierte γ-Lactonverbindungen |
| DE10137487A1 (de) | 2001-08-03 | 2003-03-27 | Gruenenthal Gmbh | Substituierte 5,6,6a,11b-Tetrahydro-7-oxa-6-aza- benzo[c]fluoren-6-carbonsäurederivate |
| DE10306202A1 (de) | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| JP4360891B2 (ja) | 2003-12-09 | 2009-11-11 | アルパイン株式会社 | 放送受信機能を備えた電子装置およびその装置における電子番組ガイドの表示方法 |
| RU2451014C2 (ru) * | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
| KR101136183B1 (ko) * | 2005-07-22 | 2012-04-17 | 모찌다 세이야쿠 가부시끼가이샤 | 신규 헤테로시클리덴 아세트아미드 유도체 |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| AU2018284335A1 (en) | 2017-06-12 | 2020-01-30 | Glytech Llc. | Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL93610A0 (en) * | 1989-03-08 | 1990-12-23 | Merck Sharp & Dohme | Tetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them |
| CA2232509A1 (en) * | 1995-09-29 | 1997-04-10 | Glaxo Wellcome Spa | Tetrahydroquinolines as nmda antagonists |
| GB9617305D0 (en) * | 1996-08-17 | 1996-09-25 | Glaxo Wellcome Spa | Heterocyclic compounds |
-
1997
- 1997-03-26 GB GBGB9706294.7A patent/GB9706294D0/en active Pending
-
1998
- 1998-03-24 CN CN98805302A patent/CN1257482A/zh active Pending
- 1998-03-24 JP JP54323498A patent/JP2001518901A/ja active Pending
- 1998-03-24 EP EP98919133A patent/EP0971896A1/en not_active Withdrawn
- 1998-03-24 EA EA199900755A patent/EA199900755A1/ru unknown
- 1998-03-24 AU AU72094/98A patent/AU731394B2/en not_active Ceased
- 1998-03-24 KR KR1019997008630A patent/KR20010005567A/ko not_active Application Discontinuation
- 1998-03-24 NZ NZ337793A patent/NZ337793A/en unknown
- 1998-03-24 IL IL13191998A patent/IL131919A0/xx unknown
- 1998-03-24 TR TR1999/02315T patent/TR199902315T2/xx unknown
- 1998-03-24 BR BR9808424-0A patent/BR9808424A/pt not_active IP Right Cessation
- 1998-03-24 HU HU0001661A patent/HUP0001661A3/hu unknown
- 1998-03-24 CA CA002284710A patent/CA2284710A1/en not_active Abandoned
- 1998-03-24 AP APAP/P/1999/001659A patent/AP9901659A0/en unknown
- 1998-03-24 WO PCT/EP1998/001700 patent/WO1998042673A1/en not_active Application Discontinuation
- 1998-03-24 YU YU47699A patent/YU47699A/sh unknown
- 1998-03-24 ID IDW991108A patent/ID24306A/id unknown
- 1998-03-24 PL PL98335865A patent/PL335865A1/xx unknown
-
1999
- 1999-09-17 IS IS5186A patent/IS5186A/is unknown
- 1999-09-24 NO NO994679A patent/NO994679L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ337793A (en) | 2001-02-23 |
| TR199902315T2 (xx) | 2000-05-22 |
| CA2284710A1 (en) | 1998-10-01 |
| NO994679D0 (no) | 1999-09-24 |
| ID24306A (id) | 2000-07-13 |
| AP9901659A0 (en) | 1999-09-30 |
| EA199900755A1 (ru) | 2000-08-28 |
| KR20010005567A (ko) | 2001-01-15 |
| CN1257482A (zh) | 2000-06-21 |
| AU731394B2 (en) | 2001-03-29 |
| IS5186A (is) | 1999-09-17 |
| HUP0001661A3 (en) | 2001-12-28 |
| AU7209498A (en) | 1998-10-20 |
| JP2001518901A (ja) | 2001-10-16 |
| PL335865A1 (en) | 2000-05-22 |
| WO1998042673A1 (en) | 1998-10-01 |
| HUP0001661A2 (hu) | 2000-09-28 |
| NO994679L (no) | 1999-11-24 |
| BR9808424A (pt) | 2000-05-23 |
| EP0971896A1 (en) | 2000-01-19 |
| IL131919A0 (en) | 2001-03-19 |
| GB9706294D0 (en) | 1997-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003020698A3 (en) | Protein tyrosine kinase inhibitors | |
| BR0315547A (pt) | Derivados de quinolina como antagonistas de crth2 | |
| TR199900049T2 (xx) | Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler. | |
| DE60037020D1 (en) | Anilinochinazoline als protein-tyrosin-kinasehemmer | |
| TR200002015T2 (tr) | Protein tirosin kinaz inhibitörleri olarak bisiklik heteroaromatik bileşikler. | |
| HUP0004490A3 (en) | Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threoning kinase inhibitors and pharmaceutical compositions containing them | |
| CA2473991A1 (en) | Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor | |
| MY115638A (en) | N-substituted heterocyclic derivatives, their preparation and pharmaceutical compositions containing them | |
| IL90435A0 (en) | 4-(quinolin-2-yl-methoxy)phenylacetic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| TR199801861T2 (xx) | Farmas�tik olarak yararl� bile�imler. | |
| EP1179533A3 (en) | Salt of naphthyridine carboxylic acid derivative | |
| TR199900336T2 (xx) | EAA antagonistleri olarak tetrahidrokinolin t�revleri. | |
| MX9801987A (es) | Nuevos derivados de aminoacido, su obtencion y su uso. | |
| YU47699A (sh) | Derivat hinolin -2-karboksilne kiseline i njegova upotreba kao antagonist ekscitatornih amino kiselina | |
| TR199800531T1 (xx) | NMDA antagonistleri olarak tetrahidrokinolinler. | |
| HUP0301080A3 (en) | Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives, process for their preparation and pharmaceutical compositions containing them | |
| CY1106105T1 (el) | Αλας μεγλουμινης ενος συγκεκριμενου κινολινοκαρβοξυλικου οξεως ενepγου επι των υποδοχεων nmda | |
| DE69922936D1 (de) | Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten | |
| TR199901380A2 (xx) | Di-ya da triazo-spiro$4,5] dekan t�revleri | |
| BG106329A (en) | Taste masking of oral quinolone liquid preparations using ion exchange resins | |
| BG105618A (en) | Beta-amido and beta-sulphonamide derivatives of carboxylic acids, method for preparation and application as endothelin-receptor antagonists | |
| IL160160A0 (en) | SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS | |
| MXPA04000952A (es) | Sales de derivados de acido 1,2,3-4-tetrahidro-isoquinolin-2-carboxilico. | |
| MY122040A (en) | 4 substituted carboxy tetrahydroquinoline derivatives | |
| BG108165A (en) | Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone |